Association of British Clinical Diabetologists (ABCD) and Diabetes UK joint position statement and recommendations for non-diabetes specialists on the use of sodium glucose co-transporter 2 inhibitors in people with type 2 diabetes (January 2021)

Sodium glucose co-transporter 2 (SGLT2) inhibitors are now an established class of medications for the treatment of type 2 diabetes (T2D), no longer reserved for use by specialists in diabetes. They are being used increasingly for their cardiac and renal benefits by primary care, cardiology and rena...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Clin Med (Lond)
Auteurs principaux: Dashora, Umesh, Gregory, Robert, Winocour, Peter, Dhatariya, Ketan, Rowles, Susannah, Macklin, Andrew, Rayman, Gerry, Nagi, Dinesh, Whitehead, Katie, Beba, Hannah, De, Parijat, Patel, Dipesh C
Format: Artigo
Langue:Inglês
Publié: Royal College of Physicians 2021
Sujets:
Concise Guidance
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC8140708/
https://ncbi.nlm.nih.gov/pubmed/34001571
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7861/clinmed.2021-0045
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires